4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0001746473-26-000055
Options or other derivatives
- Chief Operating Officer acquired 245,200 shares (grant or award)
- Chief Operating Officer returned 245,200 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kuo Minnie Chief Operating Officer | 2026-04-17 | Returned to the company · Stock Option (Right to Buy) | −150,000 | 0 | D | ||
| Kuo Minnie Chief Operating Officer | 2026-04-17 | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | D | ||
| Kuo Minnie Chief Operating Officer | 2026-04-17 | Returned to the company · Stock Option (Right to Buy) | −40,000 | 0 | D | ||
| Kuo Minnie Chief Operating Officer | 2026-04-17 | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | D | ||
| Kuo Minnie Chief Operating Officer | 2026-04-17 | Returned to the company · Stock Option (Right to Buy) | −55,200 | 0 | D | ||
| Kuo Minnie Chief Operating Officer | 2026-04-17 | Grant or award · Stock Option (Right to Buy) | +55,200 | 55,200 | D | ||
Loading xslF345X06/wk-form4_1776458567.xml…